Giuseppe Privitera

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 6

Top Topics

Ulcerative Colitis

Health Promotion

Top Venues

United European gastroenterology journal

Nature reviews. Gastroenterology & hepatology

Gastroenterology report

Inflammatory bowel diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Gabriele Dragoni, Fabiana Castiglione, Cristina Bezzio, Daniela Pugliese, Rocco Spagnuolo, Anna Viola, Francesco Cocomazzi, Annalisa Aratari, Edoardo Vincenzo Savarino, Paola Balestrieri, Sara Onali, Chiara Viganò, Davide Giuseppe Ribaldone, Tommaso Innocenti, Anna Testa, Simone Saibeni, Giuseppe Privitera, Monica Milla, Alessandro Armuzzi, Massimo Claudio Fantini, Gionata Fiorino
Comparison of two strategies for the management of postoperative recurrence in Crohn's disease patients with one clinical risk factor: A multicentre IG-IBD study. United European gastroenterology journal (2023)
Giuseppe Privitera, Nitish Rana, Alessandro Armuzzi, Theresa T Pizarro
The gasdermin protein family: emerging roles in gastrointestinal health and disease. Nature reviews. Gastroenterology & hepatology (2023)
Daniela Pugliese, Giuseppe Privitera, Luigi Larosa, Valentin Calvez, Diana Broglia, Nicoletta de Matthaeis, Alessandro Armuzzi
A rare case of epiploic appendagitis in a patient affected by ulcerative colitis on vedolizumab therapy. Gastroenterology report 10 (2022)
Giuseppe Privitera, Theresa T Pizarro
Live or let die: Translational insights and clinical perspectives of gasdermin B-dependent intestinal epithelial cell fate. Clinical and translational medicine 12 (4) (2022)
Giuseppe Privitera, Daniela Pugliese, Alessandro Armuzzi, Luisa Guidi
Dual Targeted Therapy in Patient With Extensive Crohn's Disease: Different Response at Distinct Location. Inflammatory bowel diseases 27 (8) (2022)
Daniela Pugliese, Giuseppe Privitera, Francesca Rogai, Angela Variola, Anna Viola, Lucrezia Laterza, Antonino C Privitera, Mariangela Allocca, Fabrizio Bossa, Maria Cappello, Marco Daperno, Greta Lorenzon, Silvia Mazzuoli, Mariabeatrice Principi, Renato Sablich, Luisa Moser, Antonio Ferronato, Sara Traini, Gherardo Tapete, Giorgia Bodini, Maria Di Girolamo, Laurino Grossi, Giammarco Mocci, Chiara Ricci, Simone Saibeni, Stefano Festa, Rocco Spagnuolo, Claudio C Cortelezzi, Filippo Mocciaro, Fernando Rizzello, Alessandro Armuzzi, null null
Two-year effectiveness and safety of golimumab in ulcerative colitis: An IG-IBD study. United European gastroenterology journal 9 (1) (2021)